Latest Videos |view all videos
Ronald Petersen, M.D., Ph.D., discusses a new scoring system to help determine which elderly people may be at a higher risk of developing the memory and thinking problems that can lead to dementia.
By examining more than 3,600 postmortem brains, researchers at Mayo Clinic have found that the progression of dysfunctional tau protein drives the cognitive decline and memory loss seen in Alzheimer's disease.
Researchers at Mayo Clinic's campus in Florida have developed a mouse model that exhibits the features associated with the most common genetic form of ALS and frontotemporal dementia.
Michelle M. Mielke, Ph.D., presents Identifying and Translating Biomarkers for Neurodegenerative Diseases: Experience With Sphingolipids.
Dean M. Wingerchuk, M.D., neurologist at Mayo Clinic's campus in Arizona, explains how the future holds promise for multiple sclerosis research.
A clinical trial co-led by Mayo Clinic Cancer Center researchers found that adding chemotherapy following radiation treatment improved survival for adults with low-grade gliomas by more than five years.
A diagnosis of chronic obstructive pulmonary disease (COPD) in older adults was associated with increased risk of mild cognitive impairment (MCI), especially MCI of skills other than memory.
Benjamin L. Brown, M.D., cerebrovascular and endovascular neurosurgeon at Mayo Clinic's campus in Florida, talks about AVMs, their relationship to stroke, current controversy over treatments and options for therapy.
Kevin M. Barrett, M.D., vascular neurologist at Mayo Clinic's campus in Florida, talks about the second phase of the international stroke trial and how to refer patients for participation. Dr. Barrett shares information about the seven-year ...